Efforts like the Rostock International PD (ROPAD) and the LRRK2/Luebeck International PD (LIPAD) studies aim at genetic classification and deep phenotyping of PD patients and healthy carriers of pathogenic variants (Skrahina et al. 2021; Usnich et al. 2021). Here, LRRK2 is linked to Parkinson disease.